Doctors often use a machine to clean blood in very sick patients. This is called CRRT. Two common methods keep blood from clotting in the machine. One uses citrate. The other uses heparin. Both have pros and cons. But which one saves more money and works better? That's what experts wanted to find ou
Retinitis pigmentosa (RP) is a tricky condition. It's caused by faults in over 90 different genes. This makes it hard to treat because each case can be unique. Right now, gene therapies are limited and expensive. So, scientists are looking for a different approach. One that doesn't depend on the spe
Chordoma is a tough cancer to treat. It's rare, and doctors don't have many options. But there's a new drug called palbociclib that might help. Researchers tested palbociclib on people with advanced chordoma. They wanted to see if it could stop the cancer from growing. The results are promising. P
In a big move, Wisconsin's highest court just said the state can ban conversion therapy. This isn't just about one issue, though. It's also about who gets to make the rules in the state. The court said a group of lawmakers can't just block rules they don't like. This gives the governor more power to
IgA nephropathy is a tricky kidney problem. Doctors have a tool called the Oxford Classification to guess how it might progress. This tool looks at kidney tissue and gives scores based on certain features. But does this tool also help predict how well patients will respond to steroid treatments? Tha
Atopic dermatitis, often called eczema, is a persistent skin issue that many people deal with. It causes inflammation and can be quite uncomfortable. While there are treatments available, there isn't much real-world data on how well they work, especially for those with moderate to severe cases. Ent
Lung cancer is a serious disease. Doctors often use a mix of treatments to fight it. One common approach is neoadjuvant chemoimmunotherapy. This treatment happens before surgery. It aims to shrink tumors and make them easier to remove. But how long should this treatment last? That's a big question.
Scientists have come up with a clever way to fight cancer using a special molecule. This molecule can find and attack cancer cells in the body. The tricky part about cancer is that it can hide from the body’s defense system. But this new treatment helps the body recognize and fight cancer cells. Th
Scientists have been using a powerful new tool to fight cancer. Now, they are testing it on a different kind of battle: rheumatoid arthritis (RA). This therapy, called CAR-T cell treatment, gives immune cells superpowers to fight diseases. In RA, the body's defense system turns against itself, causi
Colorectal cancer is a serious health issue. Many people ask if capecitabine is a good choice for treatment. A recent study looked at the cost and benefits of this drug compared to active monitoring. The study focused on patients with stable or responding metastatic colorectal cancer after 16 weeks
